These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 24936530)

  • 1. Sulodexide: it is time for a program against chronic venous disease.
    Roztocil K; Antignani PL
    Int Angiol; 2014 Jun; 33(3):209-11. PubMed ID: 24936530
    [No Abstract]   [Full Text] [Related]  

  • 2. Glycosaminoglycan sulodexide modulates inflammatory pathways in chronic venous disease.
    Mannello F; Ligi D; Raffetto JD
    Int Angiol; 2014 Jun; 33(3):236-42. PubMed ID: 24936532
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of sulodexide in the treatment of CVD.
    Andreozzi GM
    Int Angiol; 2014 Jun; 33(3):255-62. PubMed ID: 24936534
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quality of live as measured by the CIVQ 20. Questionnaire following oral mesoglycan treatment of patients with chronic venous disease.
    Allegra C; Antignani PL
    Int Angiol; 2014 Oct; 33(5):407-18. PubMed ID: 24566500
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Mesoglycan and phlebopathy. A clinico-experimental contribution].
    Allegra C; Bonifacio M; Riccioni C; Tonelli V
    Minerva Med; 1986 Oct; 77(40):1887-92. PubMed ID: 2946005
    [No Abstract]   [Full Text] [Related]  

  • 6. Sulodexide in venous disease.
    Carroll BJ; Piazza G; Goldhaber SZ
    J Thromb Haemost; 2019 Jan; 17(1):31-38. PubMed ID: 30394690
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interest in both acute thromboembolism and chronic venous disease has greatly increased among vascular surgeons in recent years. Introduction.
    Gloviczki P
    Semin Vasc Surg; 2013 Mar; 26(1):1. PubMed ID: 23932555
    [No Abstract]   [Full Text] [Related]  

  • 8. Varicose veins.
    Piazza G
    Circulation; 2014 Aug; 130(7):582-7. PubMed ID: 25114187
    [No Abstract]   [Full Text] [Related]  

  • 9. The Significance of Pain in Chronic Venous Disease and its Medical Treatment.
    Radak D; Atanasijević I; Nešković M; Isenovic E
    Curr Vasc Pharmacol; 2019; 17(3):291-297. PubMed ID: 29424318
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Sulodexide in treatment of chronic venous insufficiency. Results of the All-Russian multicenter programme ACVEDUCT].
    Chupin AV; Katorkin SE; Katel'nitskiĭ II; Katel'nitskaia OV; Prostov II; Petrikov AS; Koshevoĭ AP; Liudkova LF
    Angiol Sosud Khir; 2018; 24(1):47-55. PubMed ID: 29688194
    [TBL] [Abstract][Full Text] [Related]  

  • 11. LivRelief varicose veins cream in the treatment of chronic venous insufficiency of the lower limbs: A 6-week single arm pilot study.
    Dwyer HC; Baranowski DC; Mayer PV; Gabriele S
    PLoS One; 2018; 13(12):e0208954. PubMed ID: 30596677
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Clinical aspects of deep venous varicose insufficiency].
    Petter O
    Phlebologie; 1992; 45(3):247-53; discussion 253-4. PubMed ID: 1470647
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Not Available].
    Schuller-Petrovic S
    Wien Med Wochenschr; 2016 Jun; 166(9-10):259. PubMed ID: 27342595
    [No Abstract]   [Full Text] [Related]  

  • 14. Management of chronic venous disorders of the lower limbs: guidelines according to scientific evidence.
    Nicolaides AN; Allegra C; Bergan J; Bradbury A; Cairols M; Carpentier P; Comerota A; Delis C; Eklof B; Fassiadis N; Georgiou N; Geroulakos G; Hoffmann U; Jantet G; Jawien A; Kakkos S; Kalodiki E; Labropoulos N; Neglen P; Pappas P; Partsch H; Perrin M; Rabe E; Ramelet AA; Vayssaira M; Ioannidou E; Taft A
    Int Angiol; 2008 Feb; 27(1):1-59. PubMed ID: 18277340
    [No Abstract]   [Full Text] [Related]  

  • 15. The care of patients with varicose veins and associated chronic venous diseases: clinical practice guidelines of the Society for Vascular Surgery and the American Venous Forum.
    Gloviczki P; Comerota AJ; Dalsing MC; Eklof BG; Gillespie DL; Gloviczki ML; Lohr JM; McLafferty RB; Meissner MH; Murad MH; Padberg FT; Pappas PJ; Passman MA; Raffetto JD; Vasquez MA; Wakefield TW; ;
    J Vasc Surg; 2011 May; 53(5 Suppl):2S-48S. PubMed ID: 21536172
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Micronized Purified Flavonoid Fraction (MPFF) for Patients Suffering from Chronic Venous Disease: A Review of New Evidence.
    Ulloa JH
    Adv Ther; 2019 Mar; 36(Suppl 1):20-25. PubMed ID: 30758743
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The interest and prospects of Daflon treatment in obstetrical and gynaecological practice].
    Muller P; Wolff F; Schick RA; Szwarcberg R
    Rev Fr Gynecol Obstet; 1973 May; 68(5):345-9. PubMed ID: 17474201
    [No Abstract]   [Full Text] [Related]  

  • 18. [The efficacy of Veinobiase in venous disorders presented in women taking estroprogesterone agents (a statistical study of 2,295 patients)].
    Levardon M; Vin F; Allaert FA
    Rev Fr Gynecol Obstet; 1990 Oct; 85(10):569-74. PubMed ID: 2263839
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sulodexide in the Treatment of Chronic Venous Insufficiency: Results of the All-Russian Multicenter ACVEDUCT Program.
    Chupin AV; Katorkin SE; Katelnitsky II; Katelnitskaya OV; Prostov II; Petrikov AS; Koshevoi AP; Lyudkova LF
    Adv Ther; 2020 May; 37(5):2071-2082. PubMed ID: 32112279
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chronic venous disorder registry: A new perspective.
    Chi YW; Schul M; Gibson K; Rosenblatt M; Kabnick L; Jaff M
    Phlebology; 2014 Aug; 29(7):415-27. PubMed ID: 23620584
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.